Study Details
Full Title
A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, STUDY TO EVALUATE REGN7508, A FACTOR XI
MONOCLONAL ANTIBODY, VERSUS APIXABAN AND ENOXAPARIN
FOR PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AFTER
ELECTIVE TOTAL KNEE ARTHROPLASTY (ROXI-APEX)
MONOCLONAL ANTIBODY, VERSUS APIXABAN AND ENOXAPARIN
FOR PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AFTER
ELECTIVE TOTAL KNEE ARTHROPLASTY (ROXI-APEX)
Principal Investigator
Thorsten
Seyler
Protocol Number
PRO00119175
NCT ID
NCT07015905
Phase
III
Enrollment Status
Open to Enrollment